Emily Bodnar
Analyst, H.C. Wainwright
Replay available
MiNK Therapeutics, Inc. (INKT) Q1 2026 Earnings Call
MiNK Therapeutics, Inc. (NASDAQ: INKT) Q1 2026 earnings conference call, held 2026-05-15. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Therese Hammond
Head of Development, Pulmonary Inflammatory Diseases
Melissa Orleal
Principal Financial Officer
Stephanie Perinanakar
Investor Relations
Dr. Jennifer Buhl
President and Chief Executive Officer
Mayank Mamthani
Analyst, B. Riley Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Mink Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.637 Good morning and welcome to Mink Therapeutics' first quarter 2026 conference call 00:00:05.637 -- 00:00:10.743 and webcast. All participants will be in a listen-only mode until their question 00:00:10.743 -- 00:00:15.448 and answer session. Please note this event is being recorded, and I would now like to 00:00:15.448 -- 00:00:20.934 turn the conference over to Stephanie Perinanakar from Mink Investor Relations. 00:00:20.934 -- 00:00:24.616 Stephanie, please go ahead. 00:00:25.599 -- 00:00:29.343 Thank you, Operator, and thank you all for joining us today. 00:00:29.343 -- 00:00:34.850 Today's call is being webcast and will be available on our website for replay. 00:00:34.850 -- 00:00:38.955 I'd like to remind you that this call will include forward-looking statements, including 00:00:38.955 -- 00:00:44.062 those related to our clinical development, regulatory and commercial plans, 00:00:44.062 -- 00:00:48.327 timelines for data releases, and partnership opportunities. 00:00:48.327 -- 00:00:52.072 These statements are subject to risks and uncertainties. 00:00:52.072 -- 00:00:57.218 Please refer to our SEC filings, also available on our website, for a detailed 00:00:57.218 -- 00:01:01.065 description of these risks. Joining me today are Dr. 00:01:01.065 -- 00:01:06.792 Jennifer Buhl, President and Chief Executive Officer of NECARE Tutics, 00:01:06.792 -- 00:01:12.378 Dr. Teres Hammond, Head of Development, and Melissa Orleal, Principal 00:01:12.378 -- 00:01:16.122 Financial Officer. I'd like to turn the call over to Dr. 00:01:16.122 -- 00:01:19.927 Buhl to highlight our progress from this quarter. 00:01:19.927 -- 00:01:21.789 Jennifer? 00:01:21.789 -- 00:01:26.262 Thank you, Stephanie. Good morning, everyone, and thank you for joinin...